Publicación:
Efficay of the use of Dihydroergotamine in the Management of Migraine Attacks: A Systematic Review with Meta-Analysis

Vista sencilla de ítem
dc.citation.volume84
dc.contributor.authorPacheco Barrios, Kevin
dc.contributor.authorPacheco-Barrios, Niels
dc.contributor.authorAlva-Diaz, Carlos
dc.contributor.authorVelasquez, Victor
dc.date.accessioned2018-11-05T17:50:18Z
dc.date.available2018-11-05T17:50:18Z
dc.date.issued2018-10
dc.description.abstractObjective: To evaluate the clinical efficacy of the use of ergotamines in the management of migraine attacks. Methods: A systematic search was performed in the MEDLINE and CENTRAL databases until May 2018, duplicates were eliminated, and studies were selected independently, the quality of the studies that met the inclusion criteria was evaluated. Subsequently, the results were extracted to perform a meta‐analysis of the comparable studies. The random effects model was used, and heterogeneity was assessed with I2. Results: Three studies were found that compared DHE (1mg SC) versus sumatriptan (6mg SC) and one against chlorpromazine (12.5mg IV). In one of the studies, the reduction at 2 hours in the mean intensity of headache was significantly better among those treated with chlorpromazine (p < 0.005). Besides, a meta‐analysis (2 RCTs, n = 347) with a random‐effects model was performed, the pain‐free outcome at 2 hours was evaluated in patients with migraine attacks. Higher freedom of pain was found at 2 hours in the group of patients with triptans treatment (138/175 = 78.8%) compared to DHE (103/172 = 59.8%) (RR = 3.64, 95% CI = 1.03 ‐ 12.90). Conclusion: With few studies of low‐medium quality, it was found that treatment with triptans and antiemetics are superior to DHE in patients with migraine attacks. It is recommended to carry out more high‐quality clinical trials to prove the use of DHE for the treatment of migraine attacks.es_ES
dc.description.peer-reviewRevisado por pareses_ES
dc.formatapplication/pdfes_ES
dc.identifier.citationPacheco-Barrios, K., Pacheco-Barrios, N., Alva-Diaz, C., & Velasquez, V. (2018). Efficacy of the Use of Dihydroergotamine in the Management of Migraine Attacks: A Systematic Review with Meta-Analysis. Annals of Neurology, 84, S185-S185en
dc.identifier.issn0364-5134
dc.identifier.issn1531-8249
dc.identifier.journalAnnals of Neurologyen
dc.identifier.urihttps://hdl.handle.net/20.500.14005/3922
dc.identifier.wosWOS:000446520900344
dc.language.isoeng
dc.publisherWiley Online Library
dc.relation.ispartofAnnals of Neurologyen
dc.rightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.sourceUniversidad San Ignacio de Loyolaes_ES
dc.sourceRepositorio Institucional - USILes_ES
dc.subjectTrastornos migrañososes_ES
dc.subjectCefaleas primariases_ES
dc.subjectAlcaloideses_ES
dc.titleEfficay of the use of Dihydroergotamine in the Management of Migraine Attacks: A Systematic Review with Meta-Analysisen
dc.typeinfo:eu-repo/semantics/article
dspace.entity.typePublication
Archivos
Bloque de licencias
Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
403 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
Congresos y conferencias Internacionales